4//SEC Filing
Rosett Max 4
Accession 0001415889-24-021230
CIK 0001472012other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 5:43 PM ET
Size
5.5 KB
Accession
0001415889-24-021230
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Rosett Max
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2024-08-09+190,000→ 190,000 totalExercise: $12.92Exp: 2034-08-08→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on August 9, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001994071
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 5:43 PM ET
- Size
- 5.5 KB